Chromosome 9p complex rearrangement Array-CGH FISH 9p deletion syndrome 9p duplication syndrome Phenotype-genotype correlation
Introduction
Chromosome 9 short arm monosomy and trisomy are syndromic conditions with peculiar clinical phenotypes, consequent to complete or partial 9p deletions/duplications.
Both 9p deletions and duplications are associated with mental and psychomotor retardation, hypotonia, hypertelorism and skeletal malformations. In addition, 9p deletion carriers show variable genital and/or gonadal disorders if XY patients, trigonocephaly, midface hypoplasia, small and up slanting palpebral fissures, long philtrum (Christ et al., 1999; Kawara et al., 2006; Swinkles et al., 2008) . Conversely 9p duplication carriers present with microcephaly/ brachycephaly, down slanting palpebral fissures, bulbous nasal tip, short philtrum and short neck (Fujimoto et al., 1998; Jelin et al., 2010; Zou et al., 2009 ). However, a great clinical heterogeneity is observed depending on the 9p genomic regions involved in the rearrangements. Due to this variability the precise molecular characterization of the unbalanced regions is an important tool to: (1) deepen the correlation between 9p deleted or duplicated genomic regions and phenotypic features, (2) define critical minimum overlap regions for the phenotype to refine or confirm those that have been proposed, (3) provide an "ad hoc" genetic counseling.
We present a 7-year-old male patient with an inverted duplication and a terminal deletion of the short arm of chromosome 9. The rearrangement has been finely characterized by array-based Comparative Genomic Hybridization (array-CGH) and Fluorescent In Situ Hybridization (FISH). Moreover we address the correlation between the patient's clinical manifestations and the regions involved in the rearrangement by comparison to the clinical presentation and the 9p genomic imbalances of other reported cases.
Materials and methods

Clinical description
The patient is a 7 years old Caucasian boy, showing developmental delay and craniofacial anomalies. He is the first child of nonconsanguineous parents with an unremarkable family history for genetic disorders. Prenatal ultrasound monitoring revealed macrosomy. Pregnancy and delivery were normal. At birth he presented a duodenal stenosis, surgically corrected. In his first year of life he showed Gene 502 (2012) Contents lists available at SciVerse ScienceDirect Gene j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / g e n e laryngomalacia, gastroesophageal reflux, bilateral cryptorchidism, ostium secundum interatrial defect and developmental delay.
Our clinical evaluation at 7 years of age revealed hypotonia and ataxia, brachycephaly, asymmetric, round and flat face with hypoplasic midface, hypertelorism, strabismus, wide nasal bridge and bulbous nose, long and smooth philtrum, thin upper lip, open mouth appearance, high-arched palate and low-set ears ( Fig. 1 and Supplementary  Fig. 1 ). Short neck, pectus carinatum, heart murmur, wide-spaced nipples and dorso lumbar scoliosis were also noted; testicles spontaneously descended and no hypospadias was present. Auxological data were the following: weight and length 25th-50th percentile and OFC 75th percentile. Blood analyses for hematochemical parameters, thyroid function and metabolic disorders screening provided normal results. Abdominal ultrasound also showed normal patterns. In order to better characterize the neurological involvement, a specialist examination was performed which evidenced a severe developmental delay. Electroencephalogram was normal while cerebral magnetic resonance showed the presence of hypoplasia of corpus callosum and brain-stem.
Cytogenetic and Fluorescent In Situ Hybridisation (FISH) Analysis
Cytogenetic analysis was performed on peripheral blood lymphocytes from the patient and his mother (father not available) using QFQ banding techniques on metaphase chromosomes obtained by standard procedures. The karyotype was described in accordance with ISCN 2009 (Shaffer and Slovak, 2009) . The BAC probes used in the FISH study were selected according to the University of California, Santa Cruz (UCSC) Genome Browser (release March 2006) and provided by Prof. Mariano Rocchi (University of Bari, Italy). BAC probes were nick translation labelled with biotin-dUTP (La Roche) or Cy3-dUTP (Amersham), and detection of biotin-dUTP labelled probe made by DEAC-streptavidin. The standard FISH protocol was followed with minor modifications (Lichter and Cremer, 1992) .
High resolution array comparative genomic hybridization (array-CGH) analysis
Genomic DNA was purified from peripheral blood mononucleate cells by using the GenElute™ Blood Genomic DNA kit (Sigma-Aldrich) according to the supplier's instructions. Array-CGH was performed by using the 244 K Human Genome CGH Microarray Kit (Agilent, Santa Clara, CA) with a mean resolution of~50 kb. Protocol provided by Agilent has been followed with no modifications. The arrays were analyzed with the Agilent Scanner Control (v 7.0) and the Feature Extraction software (v 9.5.1). Graphical overviews were obtained using the CGH Analytic software (v4.0.81). Nucleotide designations were assigned according to the hg18 build of the human genome.
Microsatellites analysis
Segregation analysis of polymorphic loci was performed on patient and his mother (father not available) using microsatellites mostly spanning the chromosome 9 deleted and duplicated regions. The following polymorphic markers were used: D9S1813, D9S286, D9S157, D9S169, D9S1817, D9S1791, D9S1799, D9S167, D9S1872. Primers sequences and positions are available on UCSC Genome Browser (release March 2006; http://genome.ucsc.edu/cgi-bin/hgGateway).
Polymerase chain reaction (PCR) assays were developed and optimized to amplify each fragment containing a marker of interest in a 15-μl volume using TaqGold 0.15 u (Biorad, Hercules, CA) and GeneAmp PCR Gold Buffer 10× (Biorad, Hercules, CA) with 50-100 ng DNA and 0.1 μM each primer. Final products were prepared for injection on the ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA), using deionized formamide, 0.5 μl GS ROX500 size standard (Applied Biosystems, Foster City, CA) and 1.0 μl PCR products. Products were separated by POP4 and analyzed by GeneScan.
Results
The QFQ-banding analysis revealed the presence of one chromosome 9 abnormal in the short arm (Fig. 2a) ; to exclude any low rate mosaicism the analysis has been extended to 100 mitoses. Array-CGH analysis identified an 18.3 Mb 9p terminal deletion (breakpoint at 9p22.2) and a 21.5 Mb duplication of the adjacent region with telomeric breakpoint at 9p22.2 and centromeric breakpoint at 9p13.1 (Fig. 2b) . Double colour FISH with BAC probes RP11-3J10 (located at 9p13.2) and RP11-108C23 (located at 9p11.2 and co-hybridizing to the pericentromeric region of chromosome 9q) allowed us to establish that the duplication also encompasses the 9p11.2 band and is an inverted duplication (Fig. 2c) . The proband's karyotype could thus be defined as 46,XY, der(9)del(9)(p22)dup(9)(p22p11.2).ish dup(9)(p13.2p11.2)(RP11-3J10++,RP11-108C23++).arr 9p24.3p22. 2(194,193-18,341,167)x1, 9p22.2p13.1(18,368,491-39,884,938) x3. The cytogenetic and array-CGH analyses of the proband's mother gave normal results, while the father was not available.
Microsatellites analysis was carried on DNAs from the patient and his mother using markers located into the deleted and duplicated regions. Informative markers allowed us to deduce the paternal origin of the rearrangement: unbalanced ratio between areas of paternal and maternal allele peaks was indicative of a double contribute from the father in the duplicated region previously identified by array-CGH analysis. Table 1 shows the observed segregation pattern.
Discussion
Here we present a male patient carrying an abnormal short arm of chromosome 9 identified by QFQ banding and subsequently refined by array-CGH and FISH as a complex rearrangement with a 9p24.3p22.2 terminal deletion and an adjacent 9p22.2p11.2 inverted duplication. Microsatellites analysis allowed us to deduce that rearrangement in the patient occurred on chromosome 9 inherited from the father.
In Fig. 3 our patient's unbalanced regions are compared to previously reported cases of 9p duplications with associated deletions, 9p 
partial duplications and 9p partial deletions which have been finely characterized by array-CGH, FISH, Multiple Ligation-Dependent Probe Amplification (MLPA) or microsatellites analysis. The phenotypes of the patients at comparison, each identified by his/her 9p rearrangement, are summarized in Table 2 . With regard to 9p deletion syndrome a critical region involved in gonadal dysgenesis in XY patients has been proposed to reside at 9p24.3, from 9p telomere to the DMRT genes cluster (Barbaro et al., 2009; Ogata et al., 1997) . The phenotype of XY patients with terminal 9p deletions varies from complete sex reversal to milder phenotypes. Genes belonging to DMRT1, 2 and 3 cluster have been proposed as candidates, since they are involved in the vertebrate sexdetermining pathway and exhibit a gonad-specific expression pattern. This 9p24.3 critical region is included in the deletion of our patient, who only shows bilateral cryptorchidism, a mild genital/ gonadal phenotype. Different critical regions have been suggested for the consensus phenotype associated to 9p deletion syndrome (Christ et al., 1999; Faas et al., 2007; Kawara et al., 2006; Swinkles et al., 2008) . The first, proposed in 1999 (Christ et al., 1999 ) is associated with developmental delay/mental retardation, trigonocephaly, midface hypoplasia and long philtrum. Subsequently, efforts to narrow down the critical region have been attempted. Swinkles et al. (2008) proposed a 300 kb long critical region in 9p22.3, while Faas et al. (2007) and Kawara et al. (2006) proposed wider and more distally extending regions in 9p23p22.3 (Fig. 3) . Typical features of 9p monosomy syndrome such as midface hypoplasia, hypertelorism, long philtrum, anomalous auricles and broad neck are present in our patient, but not micrognathia and up slanting palpebral fissures. Cardiac defects, inguinal hernia and scoliosis, all present in our case, have been rarely observed (Swinkles et al., 2008) . Trigonocephaly is considered the most prominent feature of 9p deletion syndrome consensus phenotype. This anomaly is not present in our patient, although his deletion overlaps all critical regions proposed for the 9p deletion syndrome consensus phenotype. We speculate that his duplicated region influenced the cranial features more than the flanking deletion. Indeed, in addition to the terminal deletion, our patient carries an adjacent duplication involving the 9p22.2p11.2 segment. The 9p22 band has been proposed as the candidate region for the consensus phenotype of the 9p duplication syndrome (Fujimoto et al., 1998) . Described patients had developmental delay/ mental retardation, small stature, microcephaly/brachycephaly, down slanting palpebral fissures, deep-set eyes, hypertelorism, low-set ears, bulbous/prominent nose, downturned mouth and limb anomalies (Fujimoto et al., 1998) . Recently, Jelin et al. (2010) characterized a 31.1 Mb duplication from 9p telomere to 9p21.1 in a female patient showing in addition short philtrum, orofacial clefting and thoracic kyphosis. Duplications in 9p21.3p13.2 and in 9p22.3p21.1 in patients with milder dysmorphic features, growth retardation and speech/language delay have been also reported (Bonaglia et al., 2002; Zou et al., 2009 ). Interestingly, Stumm et al. (2002) described a phenotypically normal male carrying an interstitial duplication of 9p21p12, indicating in 9p21 band the distal boundary of the critical region for 9p duplication syndrome. A mosaic supernumerary marker chromosome involving part of the short arm of chromosome 9 has been described in a patient showing a subset of the 9p duplication features, likely due to the mosaic nature of the marker (Abu-Amero et al., 2010). Our patient manifests brachycephaly, down slanting palpebral fissures, hypertelorism, low-set ears, bulbous/prominent nose and skeletal malformation. Moreover, it is important to notice that cleft palate or other palate malformations are described in all reviewed patients with 9p duplication except in the patients described by Zou et al. (2009) and Abu-Amero et al. (2010) , suggesting that a palate malformation predisposing region may resides in 9p22.2p22.1 if duplicated.
The coexistence of partial 9p monosomy and trisomy has been described in other cases discussed in the present paper ( Fig. 3 and Table 2 ) (Al Achkar et al., 2010; Hulik et al., 2009; Swinkles et al., 2008) . All show features shared by 9p deletion and 9p duplication syndromes, such as developmental delay, psychomotor retardation, hypotonia and low-set ears, but the manifestation of syndromespecific features is variable and depends on the length of the different genomic regions involved. Among the 9p deletion dysmorphic features, these cases share midface hypoplasia, thin upper lip, long philtrum and micrognatia and their deleted regions overlap about 3.7 Mb of the 9p24.3p24.2 interval. Among the 9p duplication features they share only bulbous nasal tip, and their duplications overlap about 1.8 Mb in 9p22.2p22.1 (Fig. 3 and Table 2 ).
Based on the UCSC database there are about 53 genes annotated in the region deleted in our patient. Loss or mutation of a few genes such as DOCK8, KANK1(ANKRD15), SLC1A1 and GLDC, has been already associated with mental, motor retardation and/or other neurological symptoms (Bailey et al., 2011; Griggs et al., 2008; Lerer et al., 2005; Meyer et al., 2010) , making their deletion likely responsible for the severe mental and motor delay of our patient. At least 120 genes are located in the duplicated regions of our patient and some may be dosage-sensitive thus contributing to the observed phenotype.
Further studies providing for these patients a refined molecular cytogenetic characterization such as that performed in this study are needed to appoint dosage sensitive genes of chromosome 9p and assign the genes responsible for the developmental delay and craniofacial dysmorphisms of our and previously reported patients. Genetic counselling aimed at assuring the best follow-up of the patients would greatly benefit of the increased understanding of the genotype/phenotype correlations in such patients.
Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.gene.2012.04.030.
